fda novavax - Search News

FDA Punts on Major Covid-19 Vaccine Decision

FDA delays full approval of Novavax Covid-19 vaccine even though it was on track for clearance

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on track to be cleared until Tuesday afternoon, a person familiar with the situation told CNN.

The Wall Street Journal on MSN · 1d

FDA Punts on Major Covid-19 Vaccine Decision After Ouster of Top Official

The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.

Reuters on MSN · 1d

FDA misses deadline for decision on Novavax's COVID-19 vaccine, source says

The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, a source familiar with the matter told Reuters on Wednesday.

STAT1d

Pharmalittle: We’re reading about a pharma tariff exception, FDA inspection cutbacks, and more

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...

3don MSN

New FDA commissioner agreed to oust top vaccine regulator after private swearing-in

Food and Drug Administration Commissioner Marty Makary signed off on the ouster of top vaccine official Peter Marks shortly ...

3don MSN

Vaccine stocks tumble: Moderna, Novavax, Pfizer fall after top FDA official resigns over RFK Jr. anti-vax views

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

3don MSN

Moderna and Novavax shares plunge after key FDA official steps down, citing discord with RFK Jr. who he says ‘wishes subservient confirmation of his misinformation and lies’

The forced resignation of FDA vaccine regulator Peter Marks has, in part, sparked anxiety in Big Pharma investors, as shares in Moderna and Novavax slide. Marks’ departure comes amid a sweeping ...

Drugmakers face market turmoil following FDA shakeup and Trump health overhaul

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results